ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 984,93
-0,99%
Dow Jones
37 903,29
0,23%
DAX
17 932,17
-1,10%
Brent Oil
83,54
-2,74%
Bitcoin
58 287,97
-3,82%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Exelixis Inc (EXEL)

  7. Exelixis Inc (EXEL) Actualités

EXEL Exelixis Inc

21,925
-1,54 (-6,54%)
Après les heures de négociation
Dernière mise à jour : 23:27:13
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Exelixis Inc EXEL NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-1,54 -6,54% 21,925 23:27:13
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
21,64 20,69 22,24 21,925 23,46
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
30/4/202422:05BWExelixis Announces First Quarter 2024 Financial Results and..
16/4/202422:05BWExelixis to Release First Quarter 2024 Financial Results on..
28/2/202400:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202400:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202400:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202400:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202400:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202400:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202422:05BWExelixis to Webcast Fireside Chats as Part of Investor..
24/2/202400:33EDGAR2Form 144 - Report of proposed sale of securities
22/2/202423:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202401:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202415:19EDGAR2Form SC 13G - Statement of acquisition of beneficial..
06/2/202422:49EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
06/2/202422:28EDGAR2Form 8-K - Current report
06/2/202422:05BWExelixis Announces Fourth Quarter and Fiscal Year 2023..
01/2/202422:05BWExelixis to Webcast Fireside Chats as Part of Investor..
25/1/202414:00BWExelixis Announces Detailed Results of Phase 3 CONTACT-02..
23/1/202422:05BWExelixis to Release Fourth Quarter and Fiscal Year 2023..
23/1/202408:57DJFRIpsen s'apprête à présenter de nouvelles données positives..
22/1/202423:00BWOpdivo® (nivolumab) in Combination with CABOMETYX®..
18/1/202422:05BWEuropean Patent Office Rules in Favor of Exelixis on..
17/1/202402:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202402:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202402:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202402:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202402:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202403:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202403:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202403:03EDGAR2Form 3 - Initial statement of beneficial ownership of..
10/1/202403:03EDGAR2Form 3 - Initial statement of beneficial ownership of..
08/1/202415:06EDGAR2Form 8-K - Current report
07/1/202422:00BWExelixis Announces Preliminary Fiscal Year 2023 Financial..
02/1/202422:05BWExelixis to Present at the 42nd Annual J.P. Morgan..
20/12/202322:20EDGAR2Form 8-K - Current report
15/12/202301:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202301:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202322:56EDGAR2Form 144 - Report of proposed sale of securities
13/12/202322:27EDGAR2Form 144 - Report of proposed sale of securities
12/12/202322:26EDGAR2Form 144 - Report of proposed sale of securities
07/12/202322:05BWExelixis 2023 R&D Day: Science & Strategy to be Webcast on..
05/12/202300:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202314:02BWExelixis Announces Initiation of the STELLAR-305 Phase 2/3..
04/12/202314:00BWExelixis and Arcus Biosciences Announce Clinical Trial..
30/11/202322:10EDGAR2Form 144 - Report of proposed sale of securities
29/11/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202322:05BWExelixis to Present at the Piper Sandler 35th Annual..
21/11/202301:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/11/202315:00BWExelixis Announces Encouraging Results from Expansion Cohort..
09/11/202322:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Dernières Valeurs Consultées

NASDAQ
EXEL
Exelixis
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés